Tickers

1. Composite Trajectory Verdict

For an exploration and production company with significant capital expenditure requirements and commodity price sensitivity, operating cash flow matters most because it directly funds development drilling, debt service, and shareholder returns, though all three statements carry weight given the sector's balance sheet intensity.

Composite Trajectory: Improving

Annual results show consistent improvement across all three statements: revenue grew 22% from $4.33B to $5.28B (10-K FY2024 vs FY2025, Consolidated Statements of Operations), operating income swung from $0.5M to $884M (same source), and net income rose from $94M to $675M (same source). Operating cash flow nearly doubled from $849M to $1.63B (10-K FY2024 vs FY2025, Consolidated Statements of Cash Flows), turning free cash flow (operating minus investing) positive at $553M vs $135M. The balance sheet strengthened with total liabilities falling from $5.79B to $5.53B and total equity rising from $7.22B to $7.72B (10-K 2024-12-31 vs 2025-12-31, Consolidated Balance Sheets). Quarterly trends are also positive but include the HG Acquisition (closed Feb 3, 2026) and Utica Divestiture (closed Feb 23, 2026), making organic isolation difficult; six-month revenue rose 32% to $3.50B and operating income rose 132% to $1.10B (10-Q 2026-06-30, MD&A segment tables).

2. Red Flags

• Contract termination, loss contingency, and settlement expenses jumped from $4.5M (FY2024) to $28.0M (FY2025) (10-K FY2024 vs FY2025, MD&A Exploration and Production Segment) and were $13.6M in Q2 2025 alone (10-Q 2026-06-30, MD&A three-month segment table), labeled as "loss contingencies recorded" without further quantification.
• Marketing segment persistently operates at a loss: -$65.8M (FY2024), -$64.3M (FY2025) (10-K FY2024 vs FY2025, MD&A segment operating income), -$18.2M (Q2 2025), -$16.0M (Q2 2026) (10-Q 2026-06-30, MD&A three-month segment tables).
• Interest expense surged 88% to $38M in Q2 2026 from $20M in Q2 2025 due to $1.5B Term Loan and $750M 2036 Notes issued for the HG Acquisition (10-Q 2026-06-30, MD&A Items Not Allocated to Segments).
• Commodity derivative fair value gains are large, volatile, and non-cash until settled: $111M gain (FY2025) vs $1M (FY2024) (10-K FY2024 vs FY2025, MD&A Commodity derivative fair value gains); $161M gain (Q2 2026) vs $53M (Q2 2025) (10-Q 2026-06-30, MD&A Commodity derivative fair value gains), with settled cash flows sometimes opposite in sign (e.g., $17M cash payments in FY2025 vs $10M cash proceeds in FY2024 per 10-K).
• Ad valorem taxes fell $115M in FY2025 due to a lag (2022 vs 2023 commodity prices) per 10-K MD&A, creating a potential reversal risk if prices remain elevated.
• Financing cash outflows increased to $343M in FY2025 from $135M in FY2024, driven by $136M share repurchases and $142M senior note redemptions/repurchases (10-K FY2024 vs FY2025, Consolidated Statements of Cash Flows and MD&A Financing activities).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Annual GAAP results improved markedly: total revenue increased 22% to $5.28B (FY2025 vs FY2024, 10-K Consolidated Statements of Operations); operating income rose from $0.5M to $884M; net income attributable to common shareholders climbed from $57M to $634M; basic EPS grew from $0.18 to $2.05 (same source). Realized prices (after derivatives) rose 20% to $3.97/Mcfe (10-K FY2024 vs FY2025, MD&A selected operating data). Production was flat at ~1,256 Bcfe (same source). Six-month results also show growth: revenue +32% to $3.50B, operating income +132% to $1.10B (10-Q 2026-06-30, six-month segment tables), though these include ~5 months of HG Acquisition contribution and exclude Utica Shale post-divestiture. Quarterly Q2 revenue rose 20% to $1.56B and operating income 83% to $375M (same source, three-month tables). The marketing segment loss narrowed slightly annually but persists.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Annual operating cash flow nearly doubled from $849M (FY2024) to $1.63B (FY2025) (10-K FY2024 vs FY2025, Consolidated Statements of Cash Flows), driven by higher natural gas revenues, lower ad valorem taxes, lower interest expense, and working capital changes per MD&A. Investing cash outflows increased from $714M to $1.08B, reflecting $253M of asset acquisitions and higher drilling/completion (+$71M) and leasing (+$38M) activity (same source, MD&A Investing activities). Free cash flow (operating minus investing) swung from +$135M to +$553M. Financing outflows rose to $343M from $135M due to $142M senior note redemptions/repurchases and $136M share repurchases (same source, MD&A Financing activities). No quarterly cash flow statements are provided in the 10-Q filings, limiting intra-year trend analysis.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Total assets were stable at $13.0B (2024) to $13.2B (2025) (10-K 2024-12-31 vs 2025-12-31, Consolidated Balance Sheets). Total liabilities declined from $5.79B to $5.53B, while total equity rose from $7.22B to $7.72B (same source). Long-term debt decreased slightly from $1.49B to $1.40B (same source), though post-balance-sheet the company added $1.5B Term Loan and $750M 2036 Notes and retired $365M 2029 Notes (10-K MD&A Financing Highlights and 10-Q 2026-06-30 MD&A Financing Highlights). Credit Facility borrowings rose modestly from $393M to $439M (10-K MD&A Interest expense). Derivative assets increased significantly: current from $1.05M to $68.9M, non-current from $1.3M to $12.5M (same source, Balance Sheets). Assets held for sale ($775M) and liabilities held for sale ($102M) appeared at year-end 2025 reflecting the pending Utica Divestiture (same source). Noncontrolling interests fell from $195M to $165M (same source).

6. Data Gaps

• Quarterly statements of cash flows for Q2 2025, Q2 2026, and six-month periods (not included in 10-Q 2026-06-30 provided text)
• Full condensed balance sheets as of June 30, 2026 and March 31, 2026 (only Term Loan balance of $1.1B disclosed in 10-Q 2026-06-30 MD&A)
• Standalone Q1 2026 and Q3 2025 income statements (only six-month and Q2 data in 10-Q 2026-06-30; Q3 2025 10-Q provided but not fully parsed here)
• Organic production, price, and cost metrics for 2026 periods excluding HG Acquisition and Utica Divestiture impacts
• Detailed debt maturity schedule and covenant compliance metrics post-HG Acquisition financing
• Cash tax outlook given NOL carryforwards ($960M federal, $1.9B state as of Dec 31, 2025 per 10-K MD&A) and $51M uncertain tax position reserve